Anatomage Unveils New Era of 3D Interactive Medical Study with Latest Platform Update
SANTA CLARA, Calif., Oct. 2, 2025 /PRNewswire/ -- Anatomage Inc., a market leader in medical visualization and education technology, is...
Cancer
AI Drug Discovery Pioneer, Nanyang Biologics Pte. Ltd., Enters into Business Combination Agreement with RF Acquisition Corp II in US$1.5B Transaction to Pursue Public Listing
Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform...
The magnetic math of breast health
COLD SPRING HARBOR, N.Y., Oct. 2, 2025 /PRNewswire/ -- Branching isn't just for trees. This biological process occurs in animal development,...
The9’s Singapore Investee NYB Announce Plan to Go Nasdaq via US$1.5 Billion Business Combination with SPAC RF Acquisition Corp II
NYB Partnered with Nvidia, HP and Equinix to Build the World's Largest Natural Compound Library for AI Drug Discovery SINGAPORE,...
The International Myeloma Foundation Welcomes Heather Cooper Ortner as New President & CEO
STUDIO CITY, Calif., Oct. 02, 2025 (GLOBE NEWSWIRE) -- The International Myeloma Foundation (IMF) announced today that Heather Cooper Ortner...
Defence Therapeutics Appoints Dr. Mark Lambermon as Head of Quality and Operations
Montreal, Quebec--(Newsfile Corp. - October 2, 2025) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"),...
Precision Cell Systems Acquires BennuBio to Enter the 3D Cell Culture Market
LIVERMORE, Calif., Oct. 1, 2025 /PRNewswire/ -- Precision Cell Systems (PCS) today announced the acquisition of BennuBio, marking a significant...
University of Rochester Medical Center Taps Qualified Health as Enterprise-Wide GenAI Solution
Qualified Health delivers generative AI technology with built-in safeguards and real-time insights to ease administrative workload and improve the patient...
ALIGNMT AI Collaborates with Leading Global Cancer Center to Advance AI Governance in Healthcare
ALIGNMT joins the MSK Innovation Hub to Collaboratively Pilot its AI Governance Platform for Operationalizing MSK's AI Lifecycle Management Framework...
OmniPathology Selects Gestalt as Digital Platform and Strategic Partner to Advance Innovation and Global Diagnostic Equity
SPOKANE, Wash., Oct. 1, 2025 /PRNewswire/ -- Gestalt, a leader in digital pathology and AI-driven laboratory solutions, is proud to announce...
Leica Biosystems Expands Leading Digital Pathology Portfolio for the US with Multiple Launches at Pathology Visions 2025
VISTA, Calif., Oct. 1, 2025 /PRNewswire/ -- In a groundbreaking showcase of innovation designed to accelerate the digital transformation of...
SOFIE Biosciences Prepares Launch of Two [18F]FAPI-74 Phase 3 Studies, following successful FDA engagement
Favorable End-of-Phase 2 meeting with U.S. FDA for FAPI-74 for GI cancers Primary and secondary endpoints met Alignment with FDA...
The Assistance Fund Opens New Program for B-Cell Lymphoma
Copay Assistance From The Assistance Fund Now Available for Eligible People Living With B-Cell Lymphoma ORLANDO, FL / ACCESS Newswire...
Medical Care Technologies (OTC Pink:MDCE) Secures Access to One of the World’s Largest Public Skin Cancer Image Databases to Accelerate AI Development
MESA, ARIZONA / ACCESS Newswire / October 1, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE), an emerging developer of...
Cancer AI Alliance Unveils First Collaborative AI Platform for Cancer Research
Secure, scalable, multi-cloud platform using federated learning aims to accelerate cancer discoveries and treatments SEATTLE, WASHINGTON / ACCESS Newswire /...
Omada Health Launches “Meal Map,” an AI-Powered Nutrition Experience Focused on Nutrient Quality, Not Calorie Counting
The approach defies the restrictive weight loss paradigm, with early results indicating increased meal tracking and member engagement1 with new...
TOMI Environmental Solutions Announces $175,000 Equipment Purchase by T.A.C.T., Signaling Continued Demand in Commercial Sector
Strategic Expansion with Leading Franchise Network Underscores Revenue Potential and Market Leadership for SteraMist iHP TechnologyFREDERICK, Md., Oct. 01, 2025...
Ernexa Therapeutics to Deliver Company Presentation at the Annual Cell & Gene Meeting on the Mesa
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), developing innovative cell therapies for the treatment of...
Fortress Biotech and Subsidiary Urica Therapeutics Announce Crystalys Therapeutics’ $205 Million Series A Financing
Dotinurad is a next-generation URAT1 inhibitor in two Phase 3 clinical trials with potential for best-in-class safety and efficacy Urica...
Fortress Biotech and Cyprium Therapeutics Announce an Update on the NDA for CUTX-101
MIAMI, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”) and its majority-owned subsidiary, Cyprium Therapeutics, Inc....